One year after receiving the Thematic Technology Transfer Medtech Voucher, check out this interview they conducted with our CSO Ilaria Poledri on the impact that the support of the TTT program had for ExCulture and the steps we’re taking to “contribute to healthcare which is better for patients and the world.”
ExCulture secures funding from the Dutch Industrial Biotech Seed Fund (managed by Capricorn Partners) and TTT Medtech
Leiden, 12th July 2024 - ExCulture B.V., a biotechnology startup focused on the development of an animal-free heparin substitute via fermentation,...